Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LMND
LMND logo

LMND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lemonade Inc (LMND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
66.700
1 Day change
-2.87%
52 Week Range
99.900
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Lemonade Inc (LMND) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. While the company has shown strong revenue growth and a promising partnership with Tesla, its financial performance remains weak with negative net income and EPS. Additionally, the lack of significant trading signals, neutral hedge fund and insider activity, and mixed analyst ratings suggest a cautious approach is warranted. Holding off for more clarity on financial performance and upcoming earnings results is advisable.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 73.872, and moving averages are converging, suggesting no clear trend. The stock is trading near resistance levels (R1: 66.965, R2: 70.838), which could limit upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment among options traders. However, implied volatility is high at 96.4 with an IV rank of 70.06, suggesting elevated risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Partnership with Tesla, providing a first-mover advantage in autonomous vehicle insurance.

  • Strong revenue growth of 53.29% YoY in Q4

  • AI-driven technology enhancing customer experience.

Neutral/Negative Catalysts

  • Negative net income (-$21.7M) and declining EPS (-30.95% YoY).

  • Concerns over achieving sustained growth and low loss ratios amidst competition.

  • Mixed analyst ratings with some downgrades and reduced price targets.

Financial Performance

In Q4 2025, revenue increased by 53.29% YoY to $228.1M, showcasing strong growth. However, net income dropped by 27.67% YoY to -$21.7M, and EPS declined by 30.95% YoY to -0.29, reflecting ongoing profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley upgraded LMND to Overweight with an $85 price target, citing the Tesla partnership as a growth driver. However, other analysts remain cautious, with Piper Sandler lowering the price target to $65 and Keefe Bruyette maintaining an Underperform rating. Analyst sentiment is mixed overall.

Wall Street analysts forecast LMND stock price to rise
6 Analyst Rating
Wall Street analysts forecast LMND stock price to rise
2 Buy
3 Hold
1 Sell
Hold
Current: 68.670
sliders
Low
40
Averages
77.6
High
98
Current: 68.670
sliders
Low
40
Averages
77.6
High
98
Morgan Stanley
Equal Weight -> Overweight
upgrade
$80 -> $85
AI Analysis
2026-03-17
Reason
Morgan Stanley
Price Target
$80 -> $85
AI Analysis
2026-03-17
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Lemonade (LMND) to Overweight from Equal Weight with a price target of $85, up from $80. The company's partnership with Tesla (TSLA) "represents an important first step" and gives Lemonade first-mover advantage in data analysis and on-the-ground experience, the analyst tells investors in a research note. Morgan Stanley says that while Lemonade is offering a 50% discount on auto insurance when full self-driving is engaged in Tesla vehicles, the company is maintaining underwriting discipline based on the quotes it viewed. It expects Lemonade to expand its autonomous exposure, driving the scale needed to "meaningfully improve" its long-term earnings profile.
Keefe Bruyette
Underperform
maintain
$40 -> $44
2026-02-24
Reason
Keefe Bruyette
Price Target
$40 -> $44
2026-02-24
maintain
Underperform
Reason
Keefe Bruyette raised the firm's price target on Lemonade to $44 from $40 and keeps an Underperform rating on the shares. 30%+ growth, sustained low loss ratios, and efficient customer acquisition spend could be "challenging" to achieve in synchrony with intensifying competition, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LMND
Unlock Now

People Also Watch